America Should Build the World's Medicine Cabinet Again " American Greatness

The article argues that the United States should rebuild its domestic pharmaceutical manufacturing capacity rather than relying on foreign factories for essential medicines. It says President Trump’s latest tariff announcement on generic pharmaceuticals signals a shift, but questions whether the timeline and supporting policies are realistic. It points to COVID-19 shortages—from antibiotics to hospital supplies—as evidence of how dependent the U.S. has become. The piece credits the administration with pushing investment, citing SelectUSA’s record $139 billion in manufacturing and advanced-industry investment this year and $20 billion in planned U.S. investments announced by Indian companies. It notes reshoring takes more than political statements, including permitting, specialized clean rooms, FDA inspections, and even electricity needs.